Your browser doesn't support javascript.
loading
Durable natural killer cell response after three doses of SARS-CoV-2 inactivated vaccine in HIV-infected individuals.
Yang, Xiaodong; Wang, Xiuwen; Zhang, Xin; Ding, Haifeng; Wang, Hu; Huang, Tao; Zhang, Guanghui; Duan, Junyi; Xia, Wei; Su, Bin; Jin, Cong; Wu, Hao; Zhang, Tong.
Afiliación
  • Yang X; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Wang X; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang X; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Ding H; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Wang H; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Huang T; Tian Yuan Studio, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang G; Tian Yuan Studio, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Duan J; Tian Yuan Studio, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Xia W; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Su B; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Jin C; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Wu H; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang T; Beijing Key Laboratory for HIV/AIDS Research, Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection, Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Chin Med J (Engl) ; 136(24): 2948-2959, 2023 Dec 20.
Article en En | MEDLINE | ID: mdl-38018259
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 4_TD Problema de salud: 2_enfermedades_transmissibles / 4_pneumonia Asunto principal: Infecciones por VIH / COVID-19 Límite: Humans Idioma: En Revista: Chin Med J (Engl) Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 4_TD Problema de salud: 2_enfermedades_transmissibles / 4_pneumonia Asunto principal: Infecciones por VIH / COVID-19 Límite: Humans Idioma: En Revista: Chin Med J (Engl) Año: 2023 Tipo del documento: Article País de afiliación: China